UNSPSC 51453200: Anthelmintic quinolines

Anthelmintic drugs made from consisting of a catabolite of tryptophan.

UNSPSC 51453200 Anthelmintic quinolines is a Class code that designates pharmaceutical products for parasitic infection treatment; however, recent state and local activity under this code shows minimal alignment with the code's nominal scope. The Illinois Department of Public Health awarded a $2,999,999.11 piggyback pharmaceutical warehouse contract to Chartwell Rx LLC through the MMCAP Infuse cooperative purchasing consortium for Doxycycline Hyclate 100mg tablets and Ciprofloxacin Hydrochloride 500mg tablets—neither of which are anthelmintic quinolines—while Seminole County, Florida issued an IFB for 1,900 units of Naloxone and 800 Safe Drug Deactivation Systems annually, a procurement equally unrelated to the code's intended product category. State and local issuers using this code span state health departments and county governments, though the recent record is too thin to identify standout repeat buyers or meaningful patterns in issuing-body types.

Activity under the code appears concentrated in Florida and Illinois based on the two posted opportunities, though the small sample size limits characterization of true geographic distribution. The Illinois Department of Public Health award (completed August 28, 2026, with initial 12-month term and renewal options through year 3) and the Seminole County IFB (posted June 30, 2026, with a July 26, 2023 response deadline) represent the only recent state and local opportunities visible in the source; both opportunities indicate that state and local procurement offices are applying this code to pharmaceutical products well outside the anthelmintic quinoline category, suggesting either classification drift or misapplication of the code to broader pharmaceutical buys. Pursuit under this code requires close attention to actual issuing-body scope documents rather than reliance on the UNSPSC taxonomy label.